Back to top

Olema Pharmaceuticals (OLMA) Receives a Buy from Goldman Sachs

In a report released today, Richard Law CFA from Goldman Sachs maintained a Buy rating on Olema Pharmaceuticals, with a price target of $20.00. Acc...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Olema Pharmaceuticals, Inc. (OLMA)